{"entity":{"type":"insider","cik":"0001669207","url":"/insider/0001669207","json_url":"/insider/0001669207.json","name":"MOORE TIMOTHY L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":7,"first":"2017-08-03","last":"2025-02-05","span_basis":"filed_date"},"name_variants":[{"name":"MOORE TIMOTHY L.","source":"filing","n_filings":7,"first_seen":"2017-08-03","last_seen":"2025-02-05"}],"transactions":[{"id":4150866,"accession":"0001737287-25-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001737287-25-000018","line_url":"/filing/0001737287-25-000018#line-1","is_derivative":false,"issuer_cik":"0001669207","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001669207","owner_cik":"0001669207","owner_name":"MOORE TIMOTHY L.","owner_display_name":"MOORE TIMOTHY L.","owner_url":"/insider/0001669207","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14746.0,"shares_display":"14,746","price_per_share":1.71,"price_display":"1.71","price_state":"stated","total_value":25215.66,"total_display":"25,215.66","total_whole":"25,216","shares_owned_after":250713.0,"shares_owned_after_display":"250,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider"},{"id":2433575,"accession":"0001209191-20-009371","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-009371","line_url":"/filing/0001209191-20-009371#line-1","is_derivative":false,"issuer_cik":"0001020214","issuer_name":"CERUS CORP","issuer_ticker":"CERS","issuer_name_source":null,"issuer_url":"/issuer/0001020214","owner_cik":"0001669207","owner_name":"MOORE TIMOTHY L.","owner_display_name":"MOORE TIMOTHY L.","owner_url":"/insider/0001669207","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3614.0,"shares_display":"3,614","price_per_share":4.7496,"price_display":"4.75","price_state":"stated","total_value":17165.0544,"total_display":"17,165.05","total_whole":"17,165","shares_owned_after":7911.0,"shares_owned_after_display":"7,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-13","scope":"insider"},{"id":9271068,"accession":"0001209191-20-009369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-009369","line_url":"/filing/0001209191-20-009369#line-1","is_derivative":false,"issuer_cik":"0001020214","issuer_name":"CERUS CORP","issuer_ticker":"CERS","issuer_name_source":null,"issuer_url":"/issuer/0001020214","owner_cik":"0001669207","owner_name":"MOORE TIMOTHY L.","owner_display_name":"MOORE TIMOTHY L.","owner_url":"/insider/0001669207","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":0.0,"shares_display":"0","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":4297.0,"shares_owned_after_display":"4,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-29","filed_date":"2020-02-13","scope":"insider"},{"id":2412652,"accession":"0001209191-20-006144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-006144","line_url":"/filing/0001209191-20-006144#line-1","is_derivative":false,"issuer_cik":"0001020214","issuer_name":"CERUS CORP","issuer_ticker":"CERS","issuer_name_source":null,"issuer_url":"/issuer/0001020214","owner_cik":"0001669207","owner_name":"MOORE TIMOTHY L.","owner_display_name":"MOORE TIMOTHY L.","owner_url":"/insider/0001669207","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3614.0,"shares_display":"3,614","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":14998.1,"total_display":"14,998.10","total_whole":"14,998","shares_owned_after":7911.0,"shares_owned_after_display":"7,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-29","filed_date":"2020-02-03","scope":"insider"},{"id":4197979,"accession":"0001209191-17-054198","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-054198","line_url":"/filing/0001209191-17-054198#line-3","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001669207","owner_name":"MOORE TIMOTHY L.","owner_display_name":"MOORE TIMOTHY L.","owner_url":"/insider/0001669207","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4228.0,"shares_display":"4,228","price_per_share":179.6639,"price_display":"179.66","price_state":"stated","total_value":759618.9692,"total_display":"759,618.97","total_whole":"759,619","shares_owned_after":45661.0,"shares_owned_after_display":"45,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-25","filed_date":"2017-09-27","scope":"insider"},{"id":4324615,"accession":"0001209191-17-047796","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-047796","line_url":"/filing/0001209191-17-047796","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001669207","owner_name":"MOORE TIMOTHY L.","owner_display_name":"MOORE TIMOTHY L.","owner_url":"/insider/0001669207","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":110.05724166666667,"price_display":"110.06","price_state":"stated","total_value":660343.45,"total_display":"660,343.45","total_whole":"660,343","shares_owned_after":49400.0,"shares_owned_after_display":"49,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-03","filed_date":"2017-08-04","scope":"insider","n_lines":2},{"id":4944513,"accession":"0001209191-17-047609","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-047609","line_url":"/filing/0001209191-17-047609","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001669207","owner_name":"MOORE TIMOTHY L.","owner_display_name":"MOORE TIMOTHY L.","owner_url":"/insider/0001669207","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":107.69349583333333,"price_display":"107.69","price_state":"stated","total_value":1292321.95,"total_display":"1,292,321.95","total_whole":"1,292,322","shares_owned_after":53492.0,"shares_owned_after_display":"53,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-01","filed_date":"2017-08-03","scope":"insider","n_lines":4},{"id":4197973,"accession":"0001209191-17-054198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-054198","line_url":"/filing/0001209191-17-054198#line-1","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001669207","owner_name":"MOORE TIMOTHY L.","owner_display_name":"MOORE TIMOTHY L.","owner_url":"/insider/0001669207","role":"Officer (EVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (EVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7511.0,"shares_display":"7,511","price_per_share":83.31,"price_display":"83.31","price_state":"stated","total_value":625741.41,"total_display":"625,741.41","total_whole":"625,741","shares_owned_after":41889.0,"shares_owned_after_display":"41,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-09-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001737287","name":"Allogene Therapeutics, Inc.","url":"/issuer/0001737287","role":"Officer (Chief Technical Officer)","n_filings":1,"first_seen":"2025-02-05","last_seen":"2025-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001020214","name":"CERUS CORP","url":"/issuer/0001020214","role":"Director","n_filings":3,"first_seen":"2020-02-03","last_seen":"2020-02-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001510580","name":"Kite Pharma, Inc.","url":"/issuer/0001510580","role":"Officer (EVP, Technical Operations)","n_filings":3,"first_seen":"2017-08-03","last_seen":"2017-09-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001669207","retrieved_at":"2026-08-22T06:25:12+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}